IDM Pharma Inc.  (IDMI) Trade Now »     Rate IDMI  -  Discuss IDMI  -  Add to Watch List        

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

IDMI: Bull or Bear?

From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bullish on IDMI ... IDMI

62%

IDM Pharma, Inc., a biopharmaceutical company, engages in the development of products to treat and control cancer. It develops product candidates to destroy residual cancer cells and to stimulate an immune response and prevent tumor recurrence. The companyÂ’s products include L-MTP-PE/MEPACT, a Phase 3 clinical trial completed liposomal muramyl-tripeptide phosphatidylethanol- amine, for the treatment of osteosarcoma; BEXIDEM, a Phase 2 clinical trial completed product for the treatment of bladder cancer; UVIDEM, a Phase 2 clinical trial dendritophage and melanoma tumor cell lysates product,... Continue reading »

From the Blogosphere

Thursday's Upgrades and Downgrades

2 %

<> Upgrades RC2 (RCRC)- Wedbush Morgan Hold » Buy Signature Bank (SBNY)- FTN Midwest Neutral » Buy Premiere Glbl Svcs (PGI)- Stanford Research Hold » Buy Holly (HOC)- BMO Capital Markets Market Perform » Outperform Meritage (MTH)- UBS Neutral » Buy Lukoil (LUKOY)- Citigroup Hold » Buy Trico Marine Services (TRMA)- Lehman Brothers Equal-weight » Overweight Downgrades Wal-Mart (WMT )- BMO Capital Markets Outperform » Market Perform Thermage (THRM)- Leerink Swann Outperform » Mkt Perform TradeStation (TRAD)- Fox Pitt Outperform » In Line Verizon (VZ)-... Continue reading »

Thursday's Upgrades and Downgrades

<> Upgrades RC2 (RCRC)- Wedbush Morgan Hold » Buy Signature Bank (SBNY)- FTN Midwest Neutral » Buy Premiere Glbl Svcs (PGI)- Stanford Research Hold » Buy Holly (HOC)- BMO Capital Markets Market Perform » Outperform Meritage (MTH)- UBS Neutral » Buy Lukoil (LUKOY)- Citigroup Hold » Buy Trico Marine Services (TRMA)- Lehman Brothers Equal-weight » Overweight Downgrades Wal-Mart (WMT )- BMO Capital Markets Outperform » Market Perform Thermage (THRM)- Leerink Swann Outperform » Mkt Perform TradeStation (TRAD)- Fox Pitt Outperform » In Line Verizon (VZ)-... Continue reading »

Bot IDM Pharma Inc. (IDMI)

5 %

e.o.m. Continue reading »

Monday's Upgrades and Downgrades

2 %

<> UPGRADES Dawson Geophys. DWSN Dahlman Rose Hold » Buy BostonPrivate Fin BPFH Sandler O'Neill Hold » Buy Progressive PGR Stifel Nicolaus Hold » Buy Wilson Greatbatch GB Banc of America Sec Neutral » Buy ArthroCare ARTC William Blair Mkt Perform » Outperform Ceragon CRNT Morgan Joseph Hold » Buy Allstate ALL Friedman Billings Mkt Perform » Outperform NOVA Chemicals NCX Lehman Brothers Underweight » Equal-weight DISH Network DISH Bernstein Underperform » Mkt Perform Harmony Gold HMY UBS Sell » Neutral Investment Tech ITG Banc of America Sec N... Continue reading »

Monday's Upgrades and Downgrades

<> UPGRADES Dawson Geophys. DWSN Dahlman Rose Hold » Buy BostonPrivate Fin BPFH Sandler O'Neill Hold » Buy Progressive PGR Stifel Nicolaus Hold » Buy Wilson Greatbatch GB Banc of America Sec Neutral » Buy ArthroCare ARTC William Blair Mkt Perform » Outperform Ceragon CRNT Morgan Joseph Hold » Buy Allstate ALL Friedman Billings Mkt Perform » Outperform NOVA Chemicals NCX Lehman Brothers Underweight » Equal-weight DISH Network DISH Bernstein Underperform » Mkt Perform Harmony Gold HMY UBS Sell » Neutral Investment Tech ITG Banc of America Sec N... Continue reading »

... more »  

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.